Published Sep 20, 2021

Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38

Dr. Matthew Johnson delves into the transformative power of psychedelics for treating mental disorders, examining their neurochemical impact, cultural and legal shifts, and the therapeutic settings crucial for efficacy and safety. Amidst growing societal acceptance, Andrew Huberman and Dr. Johnson discuss potential benefits and the complexities of managing risks associated with these profound substances.
Episode Highlights
Huberman Lab logo

Popular Clips

Episode Highlights

  • Psilocybin Benefits

    Psilocybin, a psychedelic compound, shows promise in treating mental health disorders like depression by altering self-representation. explains that psilocybin can change how individuals perceive themselves, potentially transforming their self-models and relationships with the world 1. This transformation can lead to significant therapeutic benefits, but it also carries risks, such as bad trips, which can occur even in controlled environments 2.

    The far more likely danger is the bad trip. Anyone can have this. The most psychologically healthy person in the world, probably you jack the dose high enough and especially in a less than an ideal environment you can have a bad trip.

    ---

    Despite these risks, psilocybin's potential to redefine self-perception makes it a valuable tool in mental health therapy.

       

    MDMA for PTSD

    MDMA, known for its unique neurochemical effects, is being explored for PTSD treatment. notes that MDMA increases both dopamine and serotonin, creating a rare neurochemical state that may aid in trauma processing by reducing amygdala reactivity 3. This makes MDMA potentially more suitable for trauma therapy compared to other psychedelics, as it lowers the likelihood of a bad trip 4.

    It may be that MDMA for a broader number of people is better for trauma because the chances of having an extremely challenging experience, what I call the bad trip, like really freaking out, is much lower with MDMA.

    ---

    While MDMA's therapeutic potential is promising, further research is needed to fully understand its benefits and risks.

       

    Therapeutic Environment

    The therapeutic setting is crucial for successful psychedelic therapy, as it provides a safe environment for profound experiences. describes the preparation process in clinical trials, which includes several hours of building rapport with therapists and understanding the potential effects of psychedelics 5. This preparation helps mitigate the unpredictable nature of psychedelic experiences, which can range from deeply beautiful to terrifying 6.

    You could have the most beautiful experience of your life or the most terrifying experience of your life.

    ---

    By ensuring a controlled environment, therapists can guide patients through these experiences, enhancing therapeutic outcomes.

Related Episodes